Table 6.
Stepwise multiple regression analysis detecting independent contributors to HDL-mediated cholesterol efflux capacity in all the subjects.
| Factors | β | Standardized β | P |
|---|---|---|---|
| BMI | <0.001 | −0.058 | 0.274 |
| apoCIIIHDL ratio | −0.038 | −0.325 | <0.001 |
| apoAI | 0.067 | 0.558 | <0.001 |
| hsCRP (log-transformed) | −0.002 | −0.053 | 0.348 |
| HDL-C (log-transformed) | −0.016 | −0.065 | 0.541 |
| Diabetes | −0.012 | −0.159 | 0.003 |
| Statin | −0.005 | −0.097 | 0.065 |
BMI indicates body mass index; apoCIIIHDL indicates apolipoprotein CIII in apoB-depleted plasma; apoAI, apolipoprotein AI; hsCRP, high sensitivity C reactive protein; HDL-C, high density lipoprotein-cholesterol.
R square: 0.452, P < 0.001.